Targeting the Immune System for Pulmonary Inflammation and Cardiovascular Complications in COVID-19 Patients

Targeting the Immune System for Pulmonary Inflammation and Cardiovascular Complications in COVID-19 Patients

In December 2019, following a cluster of pneumonia cases in China caused by a novel coronavirus (CoV), named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the infection disseminated worldwide and, on March 11th, 2020, the World Health Organization officially declared the pandemic of...

Full description

Bibliographic Details
Main Authors: Serena Colafrancesco, Rossana Scrivo, Cristiana Barbati, Fabrizio Conti, Roberta Priori
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-06-01
Series:Frontiers in Immunology
Subjects:
COVID-19
interleukin-6
interleukin-1
JAK inhibitors
hydroxychloroquine
ARDS
Online Access:https://www.frontiersin.org/article/10.3389/fimmu.2020.01439/full

Internet

https://www.frontiersin.org/article/10.3389/fimmu.2020.01439/full

Similar Items